Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,701 to 1,720 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A 6-Membrane Protein Gene score for prognostic prediction of cytogenetically normal acute myeloid leukemia in multiple cohorts. | J Cancer | 2020 | 31892991 | PubTator, text mining | PubMed |
| FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development. | Cancer Sci | 2020 | 31821677 | PubTator, text mining | PubMed |
A high-sensitive electrochemical DNA biosensor based on a novel ZnAl/layered double hydroxide modified cobalt ferrite-graphene oxide nanocomposite electrophoretically deposited onto FTO substrate for electroanalytical studies of etoposide. | Talanta | 2020 | 31816745 | PubTator, text mining | PubMed |
| The power and potential of integrated diagnostics in acute myeloid leukaemia. | Br J Haematol | 2020 | 31808952 | PubTator, text mining | PubMed |
| RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1. | Leukemia | 2020 | 31768017 | PubTator, text mining | PubMed |
| Detection of rare reciprocal RUNX1 rearrangements by next-generation sequencing in acute myeloid leukemia. | Genes Chromosomes Cancer | 2020 | 31756777 | PubTator, text mining | PubMed |
| Up-regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia. | J Cell Mol Med | 2020 | 31755224 | PubTator, text mining | PubMed |
| Subgroup Analysis Can Optimize the Relapse-Prediction Cutoff Value for WT1 Expression After Allogeneic Hematologic Stem Cell Transplantation in Acute Myeloid Leukemia. | J Mol Diagn | 2020 | 31751675 | PubTator, text mining | PubMed |
| Morphological characteristics, cytogenetic profile, and outcome of RUNX1-RUNX1T1-positive acute myeloid leukemia: Experience of an Indian tertiary care center. | Int J Lab Hematol | 2020 | 31725954 | PubTator, text mining | PubMed |
| Epigenetic Modifications in Head and Neck Cancer. | Biochem Genet | 2020 | 31712935 | PubTator, text mining | PubMed |
| High-content screening in zebrafish identifies perfluorooctanesulfonamide as a potent developmental toxicant. | Environ Pollut | 2020 | 31706782 | PubTator, text mining | PubMed |
| Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extramedullary Involvement in Pediatric RUNX1-RUNX1T1 (+) Acute Myeloid Leukemia. | J Pediatr Hematol Oncol | 2020 | 31688618 | PubTator, text mining | PubMed |
| SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update. | Nucleic Acids Res | 2020 | 31665520 | PubTator, text mining | PubMed |
| Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia. | Expert Rev Hematol | 2020 | 31657974 | PubTator, text mining | PubMed |
| Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells. | Oncogene | 2020 | 31649334 | PubTator, text mining | PubMed |
| Long non-coding RNA EPB41L4A-AS2 suppresses progression of ovarian cancer by sequestering microRNA-103a to upregulate transcription factor RUNX1T1. | Exp Physiol | 2020 | 31645082 | PubTator, text mining | PubMed |
| Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability. | Clin Cancer Res | 2020 | 31636099 | PubTator, text mining | PubMed |
| Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC. | J Thorac Oncol | 2020 | 31629061 | PubTator, text mining | PubMed |
| Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia. | Leukemia | 2020 | 31611628 | PubTator, text mining | PubMed |
| Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1). | Leukemia | 2020 | 31576005 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=86